Genomics

Dataset Information

0

The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma


ABSTRACT: Double Hit Lymphoma (DHL) were treated with the BRD4 inhibitor 100 nM CPI203 for 6h We used microarrays to uncover the mechanisms underlying CPI203 activity in Double Hit Lymphoma (DHL)

ORGANISM(S): Homo sapiens

PROVIDER: GSE98905 | GEO | 2017/11/01

SECONDARY ACCESSION(S): PRJNA386866

REPOSITORIES: GEO

Similar Datasets

2020-05-26 | PXD010193 | Pride
2022-03-01 | GSE149073 | GEO
| S-EPMC4654800 | biostudies-literature
| PRJNA627237 | ENA
| S-EPMC4618648 | biostudies-other
| E-GEOD-44164 | biostudies-arrayexpress
2013-12-31 | GSE44164 | GEO
2020-03-01 | GSE128728 | GEO
| S-EPMC6945775 | biostudies-literature
| PRJNA825824 | ENA